Register for our S/EIS Fund

Even the entrepreneurial and investment ecosystem has not been spared by the coronavirus. In our first exclusive global o2h ChaiTime webinar we quizzed our panelists on the future landscape for early stage investing in a post COVID-19 pandemic environment.

In the panel we had President and CEO of one of the largest healthcare technology companies, a seasoned start-up entrepreneur, an early stage Angel investor, a fund manager, a wealth manager and a start-up entrepreneur who has been featured for his AI platform that could lead to new therapeutic combinations against COVID-19.

The panelists
Deepali Nangia An angel investor and advisor to female founders

Deepali Nangia - An angel investor and advisor to female founders

Goncalo de Vasconcelos CEO of RNWL and Founder of Syndicate Room

Goncalo de Vasconcelos - CEO of RNWL and Founder of Syndicate Room

Kieran Murphy President and CEO at GE Healthcare

Kieran Murphy - President and CEO, GE Healthcare, a leading global medical technology company employing 50,000 people around the globe

Peyman Gifani CEO at AIVIVO, AI platform to support discovery therapeutics

Peyman Gifani - CEO of AIVIVO, AI platform to support discovery therapeutics

Sanjeev Gordhan Commercial Director of Newable, Technology EIS Fund

Sanjeev Gordhan - Commercial Director of Newable, Technology EIS Fund

Steve Thurlby Wealth Management Advisor, Fairstone Group

Steve Thurlby - Wealth Management Advisor, Fairstone Group

Sunil Shah CEO at o2h Ventures
(moderator)

Sunil Shah is a serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector.

Register for Invitations